53
Participants
Start Date
September 30, 2014
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Placebo
tablets
Cimetidine
Placebo
tablets
Placebo
tablets
BI 1060469 high dose
tablets
BI 1060469 low dose
tablets
Naproxen
BI 1021958
tablets
1333.43.1 Boehringer Ingelheim Investigational Site, Berlin
Lead Sponsor
Boehringer Ingelheim
INDUSTRY